Germany's BioNTech plans UK trial of mRNA cancer therapy
German pharmaceutical company BioNTech, which developed a trailblazing COVID-19 vaccine, will trial a cancer treatment in Britain using the same mRNA technology, the company said on Friday.
Jan 6, 2023
0
40